David Vetrie

13.2k citations

59 papers · 5.7k indexed · 3 hit papers · h-index 32

Impact in

Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
- Genomic variations and chromosomal abnormalities
Hematology top 1%
- Chronic Myeloid Leukemia Treatments

Papers in

Hematology 17
- Chronic Myeloid Leukemia Treatments 12
- Acute Myeloid Leukemia Research 10
Genetics 15
- Chronic Lymphocytic Leukemia Research 11
- Genomic variations and chromosomal abnormalities 5

Co-authors: Martin Bobrow Frances Flinter Tessa L. Holyoake Igor Vořechovský Lennart Hammarström Paschalis Sideras Jill Holland David Bentley
Journals: Genomics (12 papers)Blood (7 papers)Nature (3 papers)The American Journal of Human Genetics (3 papers)Nature Genetics (2 papers)
Partner nations: United Kingdom Sweden United States

In The Last Decade

David Vetrie

58 papers receiving 5.6k citations

Hit Papers

align trajectories log scale

The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML 2020 · 206 citations

Peers

Countries citing papers authored by David Vetrie

Since Specialization

Citations

This map shows the geographic impact of David Vetrie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Vetrie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Vetrie more than expected).

Fields of papers citing papers by David Vetrie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Vetrie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Vetrie. The network helps show where David Vetrie may publish in the future.

Co-authors

The 25 scholars most cited alongside David Vetrie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Vetrie Line = papers co-authored together David Vetrie links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Activating p53 abolishes self-renewal of quiescent leukaemic stem cells in residual CML disease Nature Communications ·Mary T. Scott, Wei Liu, Rebecca Mitchell, 李自生, Ross Kinstrie, 川田裕之, Elmer Schönberger, Thomas Stevens, Karen Dunn, M Raute, Mark E. Drotar, Alison M. Michie, Heather G. Jørgensen, Brian Higgins, Mhairi Copland, David Vetrie	2024	7
2	Leukaemia Exposure Alters the Transcriptional Profile and Function of Macrophages in the Bone Marrow Niche Blood ·DavidC. Wildon, Kent M. Hoffman, Nichole Dopkins, Joana Bittencourt‐Silvestre, Zeng Xianlei, Giovanny Rodriguez Blanco, Mary T. Scott, Karen Dunn, Vaidehi Krishnan, Mhairi Copland, David Vetrie, Ravi Bhatia, Seth B. Coffelt, S. Tiong Ong, Helen Wheadon, Sara Zanivan, Kristina Kirschner, G. Vignir Helgason	2023	0
3	The Spliceosome: A New Therapeutic Target in Chronic Myeloid Leukaemia Cancers ·I. López Blasco, Céline Bourgne, Chinmay Munje, Juliette Berger, AMA Boker, Pascale Cony‐Makhoul, Agnès Guerci‐Bresler, Hyacinthe Johnson‐Ansah, Wei Liu, Elahe Moazez, Andréï Tchirkov, David Vetrie, Mhairi Copland, Marc Berger	2022	3
4	ULK1 inhibition promotes oxidative stress–induced differentiation and sensitizes leukemic stem cells to targeted therapy Science Translational Medicine ·Christoph Kohl, DavidC. Wildon, Qi Xie, Mary T. Scott, Kent M. Hoffman, Karen Dunn, Nathalie Ewane Nonga, Eric R. Kalkman, Colin Nixon, Alison M. Michie, Mhairi Copland, David Vetrie, M Rennella, Barbara Saxty, G. Vignir Helgason	2021	35
5	A KDM4A-PAF1-mediated epigenomic network is essential for acute myeloid leukemia cell self-renewal and survival Cell Death and Disease ·F. van Weert, Maribel Hernández, 水本匠岐, Niamh Mannion, Manoudi Fatiha, Dian Saputra, Sandra Marmiroli, John Byron Ramos Azu, Heather G. Jørgensen, David Vetrie, Alison M. Michie, Xu Huang	2021	24
6	The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML Nature reviews. Cancer ·David Vetrie, G. Vignir Helgason, Mhairi Copland Hit paper breakdown →	2020	206
7	Epigenetic Reprogramming Sensitizes CML Stem Cells to Combined EZH2 and Tyrosine Kinase Inhibition Cancer Discovery ·Mary T. Scott, Koorosh Korfi, Peter Saffrey, Lisa Hopcroft, Ross Kinstrie, Francesca Pellicano, Carla Guenther, Paolo Gallipoli, Michelle Cruz, Karen Dunn, Heather G. Jørgensen, Jennifer Cassels, Ashley Hamilton, Andrew Crossan, Amy Sinclair, Tessa L. Holyoake, David Vetrie	2016	99
8	CML cells actively evade host immune surveillance through cytokine-mediated downregulation of MHC-II expression Blood ·Anuradha Tarafdar, Lisa Hopcroft, Paolo Gallipoli, Francesca Pellicano, Jennifer Cassels, Alan Hair, Koorosh Korfi, Heather G. Jørgensen, David Vetrie, Tessa L. Holyoake, Alison M. Michie	2016	56
9	Pillars Article: The Gene Involved in X-linked Agammaglobulinaemia Is a Member of the Src Family of Protein-Tyrosine Kinases. Nature. 1993. 361: 226–233 The Journal of Immunology ·David Vetrie, Igor Vořechovský, Paschalis Sideras, Jill Holland, Angela Davies, Frances Flinter, Lennart Hammarström, Christine Kinnon, Roland J. Levinsky, Martin Bobrow, Smith Rjh, David Bentley	2012	2
10	Complex Exon-Intron Marking by Histone Modifications Is Not Determined Solely by Nucleosome Distribution PLoS ONE ·Pawandeep Dhami, Peter Saffrey, Alexander W. Bruce, Shane C. Dillon, Kelly Chiang, Nicolas Bonhoure, Christof Koch, Jackie Bye, Keith James, Nicola Foad, Peter Ellis, Nicholas A. Watkins, Willem H. Ouwehand, Cordelia Langford, Robert Andrews, Ian Dunham, David Vetrie	2010	55
11	Autosomal-Dominant Microtia Linked to Five Tandem Copies of a Copy-Number-Variable Region at Chromosome 4p16 The American Journal of Human Genetics ·Irina Balikova, Kevin Martens, Cindy Melotte, Mustapha Amyere, Steven Van Vooren, Yves Moreau, David Vetrie, Heike Fiegler, Nigel P. Carter, Thomas Liehr, Miikka Vikkula, Gert Matthijs, Jean‐Pierre Fryns, Ingele Casteels, Koenraad Devriendt, Joris Vermeesch	2008	30
12	Requirement of bic/microRNA-155 for Normal Immune Function Science ·Antony Rodriguez, Elena Vigorito, Simon Clare, Madhuri Warren, Philippe Couttet, Dalya R. Soond, Stijn van Dongen, Russell Grocock, Partha Pratim Das, Eric A. Miska, David Vetrie, Klaus Okkenhaug, Anton J. Enright, Gordon Dougan, Martin Turner, Allan Bradley Hit paper breakdown →	2007	1561
13	Gene expression profiling in the myelodysplastic syndromes using cDNA microarray technology British Journal of Haematology ·Andrea Pellagatti, X. Li, Fiona Watkins, Cordelia F. Langford, David Vetrie, Zhenfu, Carrie Fidler, James D. Cavenagh, Camila Domingos Cabral, Peter M. Gordon, Barrie Woodcock, Beena Pushkaran, Elisabeth Aubert, James S. Wainscoat, Jacqueline Boultwood	2004	60
14	DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones. (vol 36, pg 361, 2003) ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) ·I.D. Forsythe, Philippa Carr, M S de Assumpção, Wen-Fang Lei, Heike Fiegler, Patricia Gorman, H. Motzet, Julie K. Smith, Ravindra K. Ramakrishna, David Vetrie	2003	14
15	Detection of mutations in COL4A5 in patients with Alport Syndrome Human Mutation ·Kathryn E. Plant, Peter M. Green, David Vetrie, Frances Flinter	1999	49
16	Sequence and Chromosomal Location of a Human Homologue of LRPR1, an FSH Primary Response Gene Genomics ·Roland G. Roberts, Elaine Kendall, David Vetrie, Martin Bobrow	1996	15
17	The Implications of the Cloning of the XLA Gene Journal of the Royal College of Physicians of London ·Frances Flinter, David Vetrie, Martin Bobrow	1993	1
18	Construction of a 5.2-Megabase Physical Map of the Human X Chromosome at Xq22 Using Pulsed-Field Gel Electrophoresis and Yeast Artificial Chromosomes Genomics ·David Vetrie, Martin Bobrow, Ann Harris	1993	21
19	DNA rearrangements in the α5(IV) collagen gene (COL4A5) of individuals with alport syndrome: Further refinement using pulsed-field gel electrophoresis Genomics ·David Vetrie, Eileen Boye, Frances Flinter, Martin Bobrow, Ann Harris	1992	17
20	Major rearrangements in the α5(IV) collagen gene in three patients with alport syndrome Genomics ·Eileen Boye, David Vetrie, Frances Flinter, Bhaswati Mishra, Taina Pihlajaniemi, Eija‐Riitta Hämäläinen, Jeanne C. Myers, Martin Bobrow, Ann Harris	1991	43

About David Vetrie

David Vetrie is a scholar working on Hematology, Genetics, Immunology and Allergy, Immunology and Genetics, having authored 59 papers that have together received 5.7k indexed citations. Recurring topics across this work include Immunodeficiency and Autoimmune Disorders (13 papers), Chronic Myeloid Leukemia Treatments (12 papers), Chronic Lymphocytic Leukemia Research (11 papers), Acute Myeloid Leukemia Research (10 papers), RNA and protein synthesis mechanisms (6 papers), Cell Adhesion Molecules Research (6 papers), Genomics and Chromatin Dynamics (5 papers) and Genomic variations and chromosomal abnormalities (5 papers). The work is most often cited by research in Genetics (1.2k citations), Hematology (1.1k citations), Cancer Research (1.4k citations), Immunology (1.8k citations) and Molecular Biology (3.1k citations). David Vetrie has collaborated with scholars based in United Kingdom, Sweden and United States. Frequent co-authors include Martin Bobrow, Frances Flinter, Tessa L. Holyoake, Igor Vořechovský, Lennart Hammarström, Paschalis Sideras, Jill Holland, David Bentley, Smith Rjh and Russell Grocock. Their work appears in journals such as Genomics, Blood, Nature, The American Journal of Human Genetics and Nature Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact